Menora Mivtachim Holdings Ltd 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-17 1:23 pm Unchanged | 2025-03-11 | 13G | UroGen Pharma Ltd. URGN | Menora Mivtachim Holdings Ltd | 2,303,031 4.990% | 0 (Unchanged) | Filing |
| 2024-11-14 12:04 pm Unchanged | 2024-09-30 | 13G | UroGen Pharma Ltd. URGN | Menora Mivtachim Holdings Ltd | 2,303,031 5.470% | 0 (Unchanged) | Filing |
| 2024-02-14 10:02 am Sale | 2023-12-31 | 13G | UroGen Pharma Ltd. URGN | Menora Mivtachim Holdings Ltd | 2,303,031 7.460% | -615,971 (-21.10%) | Filing |
| 2023-06-12 08:47 am Sale | 2023-06-12 | 13G | UroGen Pharma Ltd. URGN | Menora Mivtachim Holdings Ltd | 2,919,002 12.450% | -35,697 (-1.21%) | Filing |
| 2021-02-11 07:28 am Unchanged | 2020-12-31 | 13G | UroGen Pharma Ltd. URGN | Menora Mivtachim Holdings Ltd | 2,954,699 13.370% | 0 (Unchanged) | Filing |